Your browser doesn't support javascript.
loading
Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype.
Huvila, Jutta; Thompson, Emily F; Vanden Broek, Jamie; Lum, Amy; Senz, Janine; Leung, Samuel; Gilks, C Blake; Köbel, Martin; McAlpine, Jessica N; Jamieson, Amy.
Affiliation
  • Huvila J; Department of Pathology, Turku University Hospital, University of Turku, Turku, Finland.
  • Thompson EF; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Vanden Broek J; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Lum A; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Senz J; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Leung S; Department of Molecular Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Gilks CB; Department of Pathology, University of British Columbia, Vancouver, BC, Canada.
  • Köbel M; Department of Pathology, University of Calgary, Calgary, AB, Canada.
  • McAlpine JN; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Jamieson A; Department of Gynecology and Obstetrics, Division of Gynecologic Oncology, University of British Columbia, Vancouver, BC, Canada.
Histopathology ; 83(6): 880-890, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37580913

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Endometrial Neoplasms Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Histopathology Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Endometrial Neoplasms Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: Histopathology Year: 2023 Document type: Article